Aflac Inc.

Earnings Performance: Aflac Incorporated reported net earnings per diluted share of $0.05 for Q1 2025, significantly impacted by net investment losses compared to net investment gains in Q1 2024. Adjusted earnings per diluted share remained flat at $1.66, indicating stable underlying performance amidst investment volatility.

Sales Growth: Aflac Japan saw a 12.6% year-over-year sales increase, driven by strong sales of the Tsumitasu cancer insurance product, which successfully attracted younger customers. Aflac U.S. also posted a 3.5% year-over-year sales increase, particularly in group life and disability sectors, highlighting positive momentum in both international and domestic markets.

Persistent Growth Strategy: The company is focusing on maintaining strong premium persistency, which remained favorable in both Japan (93.8%) and the U.S. (79.3%). This is crucial as it offsets challenges from reinsurance and policies reaching paid-up status, positioning Aflac for continued growth.